RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Africa Channel

subscribe to Africa newsletter
Healthcare : Africa

   EMAIL   |   PRINT
HIV/AIDS trials under-represented in sub-Saharan research

Oct 6, 2005 - 9:48:00 PM
People in sub-Saharan Africa carry the heaviest burden of HIV and AIDS, yet very few trials have been conducted on the African continent over the past two decades, say researchers in recent BMJ.

 
[RxPG] A study in BMJ confirms previous findings that HIV/AIDS trials are under-represented in sub-Saharan research and suggests that publication of trial results continues to be driven by researchers external to the continent.

The team identified and mapped all randomised controlled trials on HIV and AIDS conducted wholly or partly in Africa and reported before 2004.

After extensive searching, they identified 77 trials published or reported from 1987 to 2003. Most of the trials were funded by government agencies outside Africa, pharmaceutical companies and international non-government or inter-government organisations. Few principal investigators were based in African countries and there was no mention of ethical approval or informed consent in 19 and 17 trials, respectively.

The relatively small number of HIV/AIDS trials conducted in Africa is not commensurate with the burden of disease, say the authors. This may reflect a lack of economic ability, political will, or research capacity.

Geographical mapping as an adjunct to prospective trial registration is a useful tool for researchers and decision makers to track existing and future trials, they conclude.



Publication: British Medical Journal, 1 October 2005 (Vol 331, No 7519)
On the web: Read full text of the source article at Journal's Website 

Advertise in this space for $10 per month. Contact us today.


Related Africa News
African Union and UN Agencies launch HIV Prevention Acceleration in Africa
53 African countries meet in Brazzaville to discuss scaling up of HIV prevention
HIV/AIDS trials under-represented in sub-Saharan research
Impact on child mortality of removing user fees in Africa
Notable Success in KwaZulu–Natal Malaria Crisis
91 per cent drop in Measles cases in Africa
Discriminatory Attitudes of Health Workers against People Living with HIV
WHO appoints Dr Pascoal Mocumbi as Goodwill Ambassador for maternal mortality reduction in the African Region
Road Map to Intensify Action Against TB in Africa

Subscribe to Africa Newsletter

Enter your email address:


 Additional information about the news article
Nandi Siegfried, South African Nuffield Medical Fellow, UK Cochrane Centre, Oxford, UK
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)